Luis Paz‐Ares
机构：Research Institute Hospital 12 de Octubre, Hospital Universitario 12 De Octubre · ORCID：0000-0002-1947-3364
发表论文 1380 篇 · 总被引 97378 次 · h-index 120
代表论文
- Amivantamab Plus Lazertinib in Atypical EGFR -Mutated Advanced Non–Small Cell Lung Cancer: Results From CHRYSALIS-2 (2025 · Journal of Clinical Oncology · 被引 5)
- Rilvegostomig for Metastatic Non-Small-Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study (2026 · Clinical Cancer Research)
- Author Correction: SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial (2026 · Nature Medicine)
- Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab–Based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer (2026 · Clinical Cancer Research)
- Artificial Intelligence–Based Assessment of Pathologic Response to Neoadjuvant Chemoimmunotherapy in Non–Small Cell Lung Cancer: An International Multicenter Cohort Study (2026 · SSRN Electronic Journal)
- A phase II, multicenter, open-label, single-arm study of berzosertib plus topotecan in patients with relapsed platinum-resistant small-cell lung cancer (DDRiver SCLC 250) (2025 · ESMO Open)